drugset / Trial / NCT03047057
Lidocaine Infusion in Radical Cystectomy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Radical cystectomy (RC) remains the gold standard for treatment of patients with muscle invasive bladder cancer, or recurrent high grade non-muscle invasive bladder cancer. Nowadays, enhanced recovery pathway is used to decrease morbidity and improve acute rehabilitation after RC. Postoperative ileus is the most frequent reason for prolonged hospital stay following cystectomy.
Timeline
- Start
- 2017-03-03
- Primary completion
- 2018-07-20
- Completion
- 2018-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2 mg | Intravenous |